Publications by authors named "Jeng-Sen Tseng"

Claim this Profile
L
Lauryl gallate induces apoptosis via p38-MAPK phosphorylation and autophagy in chemoresistant human lung cancer cells.
Yen-Hsiang Huang, Shur-Hueih Cherng, Ling-Yen Chiu, Kuo-Hsuan Hsu, Jeng-Sen Tseng

Arch Biochem Biophys· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual PD-1 and VEGF blockade in oncogene-negative NSCLC: where do we stand?
Jeng-Sen Tseng, Stephanie Pl Saw, Molly Sc Li

Lancet Respir Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying next-generation sequencing to predict short progression-free survival in patients with advanced EGFR -mutant lung adenocarcinoma receiving epidermal growth factor receptor tyrosine kinase inhibitors.
Po-Hsin Lee, Yi-Chun Hsiao, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng

Anticancer Drugs· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and Radiotherapy.
Tzu-I Chuang, Kuo-Hsuan Hsu, Po-Hsin Lee, Jeng-Sen Tseng, Yu-Wei Hsu

Onco Targets Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world therapeutic strategies and survival outcomes in advanced HER2 -mutant non-small cell lung cancer.
Ruei-Lin Sun, Pei-Ya Liao, Ying-Ting Liao, Yi-Chen Yeh, Chi-Lu Chiang, Jeng-Sen Tseng, Yen-Han Tseng

J Chin Med Assoc· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay of Polygenic Risk Score, Smoking Statuses, and Air Pollution on Lung Adenocarcinoma Risk in a Taiwanese Population.
I-Chieh Chen, Yi-Ming Chen, Hui-Wen Yang, Jeng-Sen Tseng, Tsung-Ying Yang

Respirology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of driver gene mutation assessment and targeted therapy for patients with early‑stage non‑small cell lung cancer and non‑R0 resection.
Pei-Yi Shen, Cheng-Yen Chuang, Chih-Hung Lin, Yu-Wei Hsu, Yen-Hsiang Huang, Jeng-Sen Tseng

Oncol Lett· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib as Second- and ≥Third-Line Treatment in Advanced and Recurrence EGFR-Mutant NSCLC Patients Harboring Acquired T790M Mutation.
Mu-Han Peng, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Po-Hsin Lee

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a Polygenic Risk Score to Improve the Risk Prediction of Non-Small Cell Lung Cancer in Taiwan.
Po-Hsin Lee, I-Chieh Chen, Yi-Ming Chen, Tzu-Hung Hsiao, Jeng-Sen Tseng

JCO Precis Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancer.
Wei-Fan Ou, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Po-Hsin Lee, Kun-Chieh Chen

Ther Adv Med Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of Examination.
Po-Hsin Lee, Wei-Fan Ou, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary tumor consolidative therapy improves the outcomes of patients with advanced -mutant lung adenocarcinoma treated with first-line osimertinib.
Jia-Jun Wu, Jeng-Sen Tseng, Zhe-Rong Zheng, Cheng-Hsiang Chu, Kun-Chieh Chen

Ther Adv Med Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemness on Chemoresistant Lung Cancer Cells by Shikonin and Synergy with BEZ235 Inhibitor.
Yen-Hsiang Huang, Ling-Yen Chiu, Jeng-Sen Tseng, Kuo-Hsuan Hsu, Chang-Han Chen

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer.
Chi-Liang Wang, Kuo-Hsuan Hsu, Ya-Hsuan Chang, Chao-Chi Ho, Chun-Ju Chiang, Jeng-Sen Tseng

J Thorac Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Thromboembolic Events and Its Influence on Survival Time of Advanced NSCLC Patients Treated with Antiangiogenic Therapy.
Wei-Fan Ou, Pei-Ya Liao, Yu-Wei Hsu, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng

Cancer Manag Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study).
Chih-Hsi Scott Kuo, Po-Lan Su, Yu-Feng Wei, Jen-Chung Ko, Jeng-Sen Tseng

Am J Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Neutrophil-to-Lymphocyte Ratio in Advanced -Mutant NSCLC Patients Treated with First-Line Osimertinib.
Kuan-Chih Chen, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Gee-Chen Chang

Onco Targets Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma.
Po-Hsin Lee, Chun-Ju Chiang, Jeng-Sen Tseng, Zhe-Rong Zheng, Kun-Chieh Chen

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan.
Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen

Target Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JMJD6/HURP axis promotes cell migration via NF-κB-dependent centrosome repositioning and Cdc42-mediated Golgi repositioning.
Yun-Ru Jaoying Huang, Shao-Chih Chiu, Jeng-Sen Tseng, Jo-Mei Maureen Chen, Tong-You Wade Wei

J Cell Physiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment.
Po-Hsin Lee, Yen-Hsiang Huang, Yu-Wei Hsu, Kun-Chieh Chen, Kuo-Hsuan Hsu, Jeng-Sen Tseng

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thoracic radiotherapy may improve the outcome of extensive stage small cell lung carcinoma patients treated with first-line immunotherapy plus chemotherapy.
Jia-Jun Wu, Jing-Wen Huang, Kuo-Hsuan Hsu, Yen-Hsiang Huang, Kun-Chieh Chen, Jeng-Sen Tseng

Anticancer Drugs· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Various impacts of driver mutations on the PD-L1 expression of NSCLC.
Cheng-Hsiang Chu, Yen-Hsiang Huang, Po-Hsin Lee, Kuo-Hsuan Hsu, Kun-Chieh Chen, Jeng-Sen Tseng

PLoS One· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced -Mutant Lung Adenocarcinoma.
Po-Hsin Lee, Yen-Hsiang Huang, Ho Lin, Kuo-Hsuan Hsu, Kun-Chieh Chen, Jeng-Sen Tseng

Medicina (Kaunas)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the Timing of Leptomeningeal Metastasis on the Outcome of -Mutant Lung Adenocarcinoma Patients and Predictors of Detectable Mutations in Cerebrospinal Fluid.
Pei-Ya Liao, Wei-Fan Ou, Kang-Yi Su, Ming-Hsi Sun, Chih-Mei Huang, Jeng-Sen Tseng

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis